# SLTM

## Overview
The SLTM gene encodes the SAFB-like transcription modulator, a multifunctional protein involved in transcriptional regulation and chromatin organization. As a member of the SAFB protein family, SLTM shares structural features such as the SAF-box and RNA-binding domains, which facilitate its interactions with DNA and RNA, respectively (Garee2009SAFB1’s; Chen2024Hypoxiainduced). The protein is implicated in various cellular processes, including transcriptional repression and activation, RNA splicing, and the formation of membraneless organelles through liquid-liquid phase separation (Orti2021Insight). SLTM's regulatory roles are particularly significant in pathways like Sonic Hedgehog (SHH) and Notch signaling, where it acts as a co-repressor or co-activator depending on the cellular context (Zhang2019A; Chen2024Hypoxiainduced). Its involvement in these pathways underscores its importance in developmental processes and disease pathogenesis, including cancer (Chen2024Hypoxiainduced).

## Structure
The SLTM (SAFB-like transcription modulator) protein is characterized by several distinct domains that contribute to its function in transcription regulation. It contains a DNA-binding SAF-box motif, which is crucial for its interaction with chromatin and transcriptional repression activities (Chen2024Hypoxiainduced). The protein also features an RNA-binding domain, which allows it to interact with RNA molecules, playing a role in RNA splicing and regulation (Garee2009SAFB1’s). 

SLTM shares structural similarities with other members of the SAFB protein family, such as SAFB1 and SAFB2, particularly in the SAP and RRM domains, which have high sequence identity with these proteins (Garee2009SAFB1’s). These domains suggest common functional roles among the family members, including transcriptional regulation and chromatin organization.

SLTM is also associated with liquid-liquid phase separation (LLPS), indicating its potential involvement in the formation of membraneless organelles, which are crucial for cellular compartmentalization and regulation (Orti2021Insight). The protein undergoes post-translational modifications, such as ubiquitination, which can lead to its degradation and influence its regulatory functions in pathways like the Notch signaling pathway (Chen2024Hypoxiainduced). 

SLTM has splice variant isoforms, which may affect its function and interactions, although specific details on these isoforms are not provided in the context.

## Function
The SLTM (SAFB-like transcription modulator) gene encodes a protein that plays a significant role in transcriptional regulation within healthy human cells. SLTM functions as a transcriptional co-repressor, modulating gene expression by interacting with GLI family zinc finger transcription factors, which are key mediators of the Sonic Hedgehog (SHH) signaling pathway. It is involved in creating a repressive chromatin environment by enhancing the binding of GLI3 repressor (GLI3R) to chromatin and increasing repressive histone marks, such as H3K27me3 and H3K9me2, at target gene loci like Gli1 (Zhang2019A).

SLTM is active in the nucleus, where it influences cell cycle progression and apoptosis. It has been shown to suppress estrogen-mediated transcription in breast cancer cells, suggesting a broader role in gene expression regulation (Wang2010A). In the context of SHH signaling, SLTM acts as a bidirectional regulator, functioning as a co-repressor under basal conditions and as a co-activator in the absence of GLI3, thereby affecting the balance between GLI activator and repressor activities (Zhang2019A). This dual functionality is crucial for maintaining genomic stability and proper cellular differentiation processes.

## Clinical Significance
Alterations in the SLTM gene, which encodes the SAFB-like transcription modulator, have been implicated in various diseases, particularly those involving dysregulation of signaling pathways. In the context of hepatocellular carcinoma (HCC), SLTM is involved in the regulation of the Notch1 signaling pathway. The degradation of SLTM by the DTL gene, under hypoxic conditions, leads to the activation of the Notch1 pathway, which is associated with increased proliferation, metastasis, and resistance to the drug sorafenib in HCC cells (Chen2024Hypoxiainduced). This suggests that SLTM plays a role in the progression of HCC and could be a potential therapeutic target.

In developmental processes, SLTM is crucial for proper Sonic Hedgehog (SHH) signaling. Its deletion in mice results in abnormal expression of ventral neural tube markers, indicating its importance in SHH-dependent development (Zhang2019A). SLTM also influences lipid metabolism and adipogenesis, as knockout of SLTM in human white adipose tissue cell lines leads to reduced lipid accumulation, although individuals with rare protein loss-of-function variants in SLTM have been observed to have a higher body mass index (Baya2024Combining).

## Interactions
The SLTM (SAFB-like transcription modulator) protein is involved in various interactions with other proteins and nucleic acids, playing a significant role in transcription regulation. SLTM interacts with the GLI family zinc finger transcription factors, including GLI1, GLI2, and GLI3, within the Sonic Hedgehog (SHH) signaling pathway. It acts as a bidirectional regulator, modulating GLI activities in a context-dependent manner. SLTM enhances GLI3's binding to chromatin and increases the levels of the GLI3 repressor form (GLI3R), promoting a repressive chromatin environment in the presence of GLI3. In the absence or low levels of GLI3, SLTM co-activates GLI activator (GLIA)-mediated gene activation (Zhang2019A).

SLTM also interacts with the Polycomb Repressive Complex 2 (PRC2), facilitating the formation of a repressive chromatin environment at the Gli1 locus by increasing specific histone marks, which enhances GLI3 binding (Zhang2019A). Additionally, SLTM is involved in the ubiquitin-mediated degradation pathway, where it is targeted by DTL, a PCNA-dependent E3 ubiquitin ligase, under hypoxic conditions in hepatocellular carcinoma. This degradation relieves SLTM's repression on the Notch1 signaling pathway, promoting cancer progression (Chen2024Hypoxiainduced).


## References


[1. (Zhang2019A) Zilai Zhang, Xiaoming Zhan, Bongwoo Kim, and Jiang Wu. A proteomic approach identifies safb-like transcription modulator (sltm) as a bidirectional regulator of gli family zinc finger transcription factors. Journal of Biological Chemistry, 294(14):5549–5561, April 2019. URL: http://dx.doi.org/10.1074/jbc.ra118.007018, doi:10.1074/jbc.ra118.007018. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.007018)

[2. (Garee2009SAFB1’s) Jason P. Garee and Steffi Oesterreich. Safb1’s multiple functions in biological control—lots still to be done! Journal of Cellular Biochemistry, 109(2):312–319, December 2009. URL: http://dx.doi.org/10.1002/jcb.22420, doi:10.1002/jcb.22420. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.22420)

[3. (Chen2024Hypoxiainduced) Zi-Xiong Chen, Mao-Yuan Mu, Guang Yang, Han Qi, Xiao-Bo Fu, Gui-Song Wang, Wei-Wei Jiang, Bi-Jun Huang, and Fei Gao. Hypoxia-induced dtl promotes the proliferation, metastasis, and sorafenib resistance of hepatocellular carcinoma through ubiquitin-mediated degradation of sltm and subsequent notch pathway activation. Cell Death &amp; Disease, October 2024. URL: http://dx.doi.org/10.1038/s41419-024-07089-4, doi:10.1038/s41419-024-07089-4. This article has 0 citations.](https://doi.org/10.1038/s41419-024-07089-4)

[4. (Orti2021Insight) Fernando Orti, Alvaro M. Navarro, Andres Rabinovich, Shoshana J. Wodak, and Cristina Marino-Buslje. Insight into membraneless organelles and their associated proteins: drivers, clients and regulators. Computational and Structural Biotechnology Journal, 19:3964–3977, 2021. URL: http://dx.doi.org/10.1016/j.csbj.2021.06.042, doi:10.1016/j.csbj.2021.06.042. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.csbj.2021.06.042)

[5. (Wang2010A) Tian-Yun Wang, Zhong-Min Han, Yu-Rong Chai, and Jun-He Zhang. A mini review of mar-binding proteins. Molecular Biology Reports, 37(7):3553–3560, February 2010. URL: http://dx.doi.org/10.1007/s11033-010-0003-8, doi:10.1007/s11033-010-0003-8. This article has 63 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11033-010-0003-8)

6. (Baya2024Combining) Combining evidence from human genetic and functional screens to identify pathways altering obesity and fat distribution. This article has 0 citations.